Form 4: Edgewell Personal Care Executive Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Eric F. O'Toole, President of North America at Edgewell Personal Care, reports the vesting of restricted stock equivalents and subsequent sale of shares to cover tax liabilities.

Summary

  • Eric F. O'Toole, President of North America at Edgewell Personal Care, filed a Form 4 detailing changes in his beneficial ownership of company stock.
  • On November 12, 2024, 1,732 restricted stock equivalents vested and were converted into common stock.
  • Also on November 12, 2024, 803 shares were sold at $35.35 per share to cover tax obligations related to the vesting.
  • Following these transactions, O'Toole directly owns 32,391 shares of Edgewell Personal Care common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not indicate any positive or negative sentiment. It is a factual report of stock transactions.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies. It provides transparency into the stock transactions of company insiders.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, as mandated by the SEC.
  • The vesting of restricted stock and subsequent sale to cover taxes is a common form of executive compensation.
  • Similar filings can be seen across the consumer goods industry, for example, with executives at companies like Procter & Gamble or Unilever.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect routine executive compensation practices.
  • The sale of shares to cover tax liabilities is a standard procedure and does not indicate any change in the company's fundamentals.

Key Dates

DateDescription
11/12/2021Date of grant for the restricted stock equivalents that vested on 11/12/2024
11/12/2024Date of restricted stock equivalent vesting and subsequent sale of shares.
11/14/2024Date the Form 4 was signed.

Keywords

Form 4, insider trading, stock transaction, restricted stock, Edgewell Personal Care, beneficial ownership, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.